Table 2. Patient (ITT) study exposure for all patients and patients who withdrew from the study.
ITT Population | |||
Parameter | AboBoNT-A | Placebo | Total |
N | 89 | 45 | 134 |
Mean (SD) days | 67.7 (38.4) | 52.5 (34.7) | 62.6 (37.8) |
CI 95% | 59.6; 75.8 | 42.1; 62.9 | 56.2; 69.1 |
Median days | 85.0 | 35.0 | 85.0 |
Min; Max | 1.0; 184.0 | 14.0; 105.0 | 1.0; 184.0 |
ITT Patients Who Withdrew From Study | |||
N | 32 | 24 | 56 |
Mean (SD) days | 19.8 (8.4) | 22.0 (8.6) | 20.7 (8.5) |
CI 95% | 16.7; 22.8 | 18.4; 25.6 | 18.4; 23.0 |
Median days | 15.5 | 18.0 | 16.0 |
Min; Max | 1.0; 37.0 | 14.0; 45.0 | 1.0; 45.0 |
aboBoNT-A = abobotulinumtoxinA; CI = confidence interval; ITT = intent-to-treat; SD = standard deviation.